Because the immune systems of people with inborn errors of immunity (IEI) don't function like everyone else's, it was unclear until now how well COVID-19 vaccinations protected them. In a new study, posted on the medRxiv ...
Apr 2, 2026
0
6
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting the gp120 on the viral ...
Feb 17, 2026
0
21
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a ...
Jan 28, 2026
0
31
Flu activity has surged in many parts of the Northern Hemisphere, driven primarily by a newly emerged H3N2 strain known as subclade K.
Dec 23, 2025
0
22
COVID rarely rates a mention in the news these days, yet it hasn't gone away.
Dec 16, 2025
0
9
An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one of the deadliest infectious diseases. In a new study in Science Advances, researchers report that a cocktail ...
Sep 10, 2025
0
59
Researchers have successfully produced antibodies that kill the parasite carried by the "kissing bug" that causes the potentially deadly Chagas disease. The research is a vital step toward the development of the first effective ...
Aug 26, 2025
0
25
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of the diverse variants of HIV. Neutralizing antibodies are proteins produced by the immune system ...
In recent years, the world has seen a surge in new and deadly infectious diseases, posing a major threat to global health. Outbreaks of COVID-19, H1N1 (swine flu), Ebola, Zika, and monkeypox are a stark reminder of our vulnerability.
May 8, 2025
0
23
A new study in the journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies against either adeno-associated virus (AAV) ...
Mar 10, 2025
0
14
